XML 24 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1Close
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Statement of Cash Flows [Abstract]      
Net income (loss) $ 1,592,000,000 $ 698,000,000 $ 1,041,000,000
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities      
Loss (gain) on disposal of businesses and assets 0 22,000,000 (78,000,000)
Depreciation and amortization 1,196,000,000 1,136,000,000 1,093,000,000
Deferred and prepaid income taxes (1,000,000) (63,000,000) (124,000,000)
Stock-based compensation expense 233,000,000 220,000,000 194,000,000
Goodwill and other intangible asset impairment charges 58,000,000 132,000,000 370,000,000
Net loss (gain) on investments and notes receivable 59,000,000 1,000,000 (250,000,000)
Contingent consideration net expense (benefit) 58,000,000 35,000,000 (136,000,000)
Inventory step-up amortization 6,000,000 32,000,000 34,000,000
Debt extinguishment net charges 0 194,000,000 0
Other, net 73,000,000 125,000,000 78,000,000
Increase (decrease) in operating assets and liabilities, excluding purchase accounting:      
Trade accounts receivable (238,000,000) (220,000,000) (279,000,000)
Inventories (660,000,000) (321,000,000) (346,000,000)
Other assets 10,000,000 (209,000,000) (134,000,000)
Accounts payable, accrued expenses and other liabilities 118,000,000 (255,000,000) 408,000,000
Cash provided by (used for) operating activities 2,503,000,000 1,526,000,000 1,870,000,000 Close
Investing Activities      
Purchases of property, plant and equipment and internal use software (711,000,000) (588,000,000) (554,000,000)
Proceeds from sale of property, plant and equipment 4,000,000 12,000,000 14,000,000
Payments for acquisitions of businesses, net of cash acquired (1,811,000,000) (1,542,000,000) (2,258,000,000)
Proceeds from (payments for) investments and acquisitions of certain technologies (89,000,000) (24,000,000) 279,000,000
Proceeds from disposal of certain businesses and assets 0 5,000,000 826,000,000
Proceeds from royalty rights 30,000,000 70,000,000 82,000,000
Proceeds from settlements of hedge contracts 2,000,000 56,000,000 15,000,000
Cash provided by (used for) investing activities (2,574,000,000) (2,011,000,000) (1,597,000,000) Close
Financing Activities      
Payment of contingent consideration previously established in purchase accounting (39,000,000) (335,000,000) (15,000,000)
Payments for royalty rights (50,000,000) (75,000,000) (85,000,000)
Payments on short-term borrowings 0 (250,000,000) 0
Net decrease in commercial paper (4,000,000) (1,000,000) 0
Payments on long-term borrowings and debt extinguishment costs 0 (3,184,000,000) 0
Proceeds from long-term borrowings, net of debt issuance costs 0 3,270,000,000 0
Cash dividends paid on preferred stock (28,000,000) (55,000,000) (55,000,000)
Cash used to net share settle employee equity awards (56,000,000) (53,000,000) (50,000,000)
Proceeds from issuances of shares of common stock pursuant to employee stock compensation and purchase plans 182,000,000 136,000,000 110,000,000
Cash provided by (used for) financing activities 5,000,000 (548,000,000) (95,000,000) Close
Effect of foreign exchange rates on cash (4,000,000) (9,000,000) (6,000,000) Close
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents (70,000,000) (1,042,000,000) 173,000,000 Close
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period 1,126,000,000 2,168,000,000 1,995,000,000
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period 1,055,000,000 1,126,000,000 2,168,000,000
Supplemental Information      
Cash paid for income taxes, net 512,000,000 662,000,000 302,000,000
Cash paid for interest 259,000,000 450,000,000 338,000,000
Fair value of contingent consideration recorded in purchase accounting 273,000,000 0 440,000,000
Non-cash impact of transferred royalty rights (30,000,000) (70,000,000) (82,000,000)
Cash and cash equivalents 865,000,000 928,000,000 1,925,000,000
Restricted cash and restricted cash equivalents included in Other current assets 130,000,000 149,000,000 188,000,000
Restricted cash equivalents included in Other long-term assets 60,000,000 48,000,000 55,000,000
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period $ 1,055,000,000 $ 1,126,000,000 $ 2,168,000,000